WHO原料药预认证的背景和程序.pdfVIP

Presentation titlePresentation title Navigating Common Challenges: Balancing High Manufacturing Quality, Safety and Low Cost Jun2012 Topics Covered Common Challenges Current Remedies New Approaches Facility Designs and Upgrades Points to Take Away Slide no 2 The Common Challenges •After one year of implementing “the Bidding Guidance”，the Sate Council reported that in 2011 the average bided prices reduced by 33% from last year. 2011-11-22 07:26 Slide no 3 The Common Challenges 【Heilongjiang】Basic Drug central bidding-- price reduced by 60% Heilongjiang News reported that Heilongjiang province completed the bidding processes, and within the 307 basic drugs, 456 products won the bid. On average, the prices reduced by 61.99%, compared with the State recommended price, within that small molecule product price reduced by 65.77% and traditional medicine price reduced by 53.6% 来源：黑龙江新闻网-黑龙江日报, 2011-05-17 /fouxw_sn/2011-05/17/content_1009321.htm Slide no 4 The Common Challenges 【Liaoning】Pharma companies debated the impact of dramatic price drop in basic drug bidding Apr 13，2010, Shenyang, the Agency of Public Health of Liaoning reported the results of basic drug bidding. On average, prices reduced by 34.30%. In some particular cases, the prices dropped by 95.82%。 source: Medical Economic Report 2010-4-19 11:13:09 /industry/market/440257.shtml Slide no 5 The Common Challenges 【Anhui】Bidding and purchase of Basic drugs: Started from Sep 20, 2010 to Sep 20, 2011，Anhui province has spent 1.417 billion RMB for purchasing bided basic drugs and provincia